Highlights

  • Lexaria’s DehydraTECHTM is a patented and proprietary drug delivery technology for delivering Active Pharmaceutical Ingredients (APIs) into the bloodstream through oral ingestion.
      • This report is currently available to premium subscribers – Free subscribers will gain access on August 23rd, 2021
        Join as a FREE member and get our research report delivered straight to your inbox, with a seven-day delay

Visit Lexaria Bioscience Corp. page for more research, discussion boards and to like, and share.


Are you enjoying the highlights?

Discover the company's fair value estimate from our certified analysts, identify potential risks, and explore exciting upcoming catalysts in our detailed report.

Already a member? Sign In

Investors are also interested in: